Search for: "US v. Michael Johnson" Results 201 - 220 of 752
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
23 Dec 2018, 7:53 am by Wolfgang Demino
(Note that the FDCPA is a federal law that applies through the US, but the state analogues of the federal fair debt collection act vary in significant ways even though they cover many of the same abusive and misleading practices. [read post]
24 Mar 2018, 12:12 pm by Gritsforbreakfast
The US Supreme Court issued a unanimous benchslapping to the Fifth Circuit Court of Appeals in Ayestas v. [read post]
10 Aug 2014, 12:30 am by Emily Prifogle
Rakove's Kennedy, Johnson, and the Nonaligned World (Cambridge University Press). [read post]
26 Apr 2012, 6:37 am by Kiran Bhat
Greg Stohr of Bloomberg reports that the ruling “may prevent the collection of $1 billion from people who used a tax shelter popular in the late 1990s and early 2000s” while Kristen Hickman and Steve Johnson analyze the decision at TaxProf Blog. [read post]
6 Apr 2014, 9:01 pm by Michael C. Dorf
Underwood uses the scandal and misuses various people in order to further his career. [read post]
9 Aug 2019, 3:00 am by Jim Sedor
Philadelphia Inquirer – Michael Brice-Saddler (Washington Post) | Published: 8/6/2019 The 44 names that U.S. [read post]
14 May 2010, 4:24 am
Please email the IPKat here with any useful information.The Advocate General's Opinion in Case C-467/08 Sociedad General de Autores y Editores (SGAE) v Padawan S.L. [read post]
12 Oct 2016, 4:28 am by Edith Roberts
Commentary comes from Michael Bobelian at Forbes. [read post]